Chief Financial Officer at Loxo Oncology
Dov A. Goldstein, M.D., 48, has served as a member of our Board since April 2008. Dr. Goldstein is a Managing Partner at Aisling Capital, a private investment firm. From October 2014 to May 2015, he served as acting Chief Financial Officer of Loxo Oncology, Inc. (NASDAQ: LOXO). He previously served as a Partner of Aisling Capital from 2008 to 2014, and from 2006 to 2008, he was a Principal at Aisling Capital. From 2000 to 2005, Dr. Goldstein was Chief Financial Officer of Vicuron Pharmaceuticals, Inc. before its acquisition by Pfizer Inc. From 1998 to 2000, Dr. Goldstein was Director of Venture Analysis at HealthCare Ventures, a privately hel ...
Source: Esperion Therapeutics, Inc. on 04/23/2015
By accessing Equilar Atlas, you can view bios, network, salary and wealth events of industry-leading executives like Dov A. Goldstein M.D.. More specifically, you'll be able to:
Search for over 360,000 executive profiles.
Example: Dov A. Goldstein M.D.
Interested in updating your biography and work history?
We're working on making it happen.
We'll email you when this feature is available.
Please enter valid email address.
Thank you for your interest.